CTLA4 and neoplasm: The 400 mm3 (at start) group treated with the anti-CTLA-4 antibody (10mg/kg, biw, ip) on day nine did not produce anti-tumor activity (P > 0.05), as the tumor volumes were 2313±234 mm3.